Send me a link:

*Text messaging rates may apply.

 Dow Down 0.64% Nasdaq Down 0.90%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
28.31 Down 0.96(3.28%) 12:27PM EDT - Nasdaq Real Time Price
Prev Close:29.27
Open:29.26
Bid:28.27 x 200
Ask:28.31 x 100
1y Target Est:39.21
Beta:1.78
Earnings Date:Oct 29 - Nov 3 (Est.)
Day's Range:28.26 - 29.56
52wk Range:27.51 - 39.95
Volume:223,117
Avg Vol (3m):607,959
Market Cap:1.16B
P/E (ttm):65.38
EPS (ttm):0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACOR

Comparison

Symbol% ChgMkt Cap
ACORDown 3.28%1.16B
BIIBDown 2.24%77.19B
TEVAUp 0.52%45.75B

Key Statistics

Forward P/E (1 yr):36.26
P/S (ttm):3.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.39
Quarterly EPS Est (Sep-14) :0.12
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):4.69

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback